Dosing is underway for the first patients enrolled in Mercury 1, the first phase 3 registration trial of Roclatan, Aerie Pharmaceuticals announced in a press release. Roclatan is a once-daily, quadruple-action eye drop being tested for its ability to l…
MacuLogix has raised $5 million in Series C funding, according to a company press release. The funding allows the company to continue expanding sales operations for the AdaptDx dark adaptometer across the U.S. and initiate commercial distribution in Eu…
Reichert Technologies announced the launch of the Ocular Response Analyzer G3 tonometer.The tool measures corneal hysteresis and provides a patented corneal compensated IOP measurement, according to a company press release.
Unhealthy lifestyle habits plus genetic risk factors can act synergistically to increase risk for age-related macular degeneration. Medscape Medical News
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE:GKOS) announced today that the United States District Court for the District of Delaware issued rulings on three pending summary judgment motions in the company’s patent lawsuit with Transcend Medical related to Transcend’s CyPass Micro-Stent. At issue in the lawsuit are three Glaukos patents related to its iStent Supra® Suprachoroidal Micro-Bypass Stent, which is currently being evaluated in a U.S. IDE pivotal trial. The patents
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells, announced today the publication of a new paper demonstrating how its synthetic Viral-like P…